| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110664 Acylated insulin |
| 06/10/2004 | US20040110663 Hedgehog antagonists, methods and uses related thereto |
| 06/10/2004 | US20040110347 Method of production of nanoparticle and nanoparticle produced by the method of production |
| 06/10/2004 | US20040110295 Plasmid that codes heterologous nucleotide sequences and is capable of expressing recombinant polypeptides eukaryotic cells; gene transfer tools |
| 06/10/2004 | US20040110282 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 06/10/2004 | US20040110273 Culture chamber for biologicals |
| 06/10/2004 | US20040110269 Protection against mycobacterial infections |
| 06/10/2004 | US20040110268 Attenuated Pasteurellaceae virulence genes are identified and used to screen bactericides and produce vaccines which prevent infection |
| 06/10/2004 | US20040110255 purposes of affinity purification or detection; increased or decreased resistance to denaturation |
| 06/10/2004 | US20040110253 used in studying T cells and their antigenic targets in autoimmunity, hypersensitivity, and cancer; for drug screening; genetic engineering |
| 06/10/2004 | US20040110252 Yeast-based assay |
| 06/10/2004 | US20040110250 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 06/10/2004 | US20040110238 Constitutively activated human G protein coupled receptors |
| 06/10/2004 | US20040110236 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 06/10/2004 | US20040110231 Screening method |
| 06/10/2004 | US20040110225 Fluorescent proteins from aquatic species |
| 06/10/2004 | US20040110218 BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes |
| 06/10/2004 | US20040110215 Of given amino acid sequence; screening for modulator ligands; vectors, antisense transcripts or mutants |
| 06/10/2004 | US20040110202 Isolated nucleic acid comprising a polynucleotide of given sequence encoding a polypeptide; culturing cell line which alters a beta processing; use in treatment of Alzheimer's disease. |
| 06/10/2004 | US20040110194 Genes regulated by human cytokines |
| 06/10/2004 | US20040110190 Isolated nucleic acid comprising a polynucleotide encoding a polypeptide which has expansin activity; altering properties which may effect growth, flexibility, and mechanical strength in tissues in which they are expressed; use in paper industry |
| 06/10/2004 | US20040110189 Comprises nucleotide sequences coding lymphocyte regulatory protein for use in treatment of allergies, cancer and asthma; tissue engineering and regeneration |
| 06/10/2004 | US20040110188 Identifying genetic region which determines monocyte tropism, leukotropism, endothelial cell tropism in human cytomegalovirus; diagnosis prevention and treatment of cell prolifefrative, atherosclerotic and autoimmune disorders |
| 06/10/2004 | US20040110185 Human hypothalmic ("HR") receptor polypeptide compositions, methods and uses thereof |
| 06/10/2004 | US20040110184 Identifying insecticidal protein specific to lepidopteran pests; cry proteins as biological pest control agents |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 06/10/2004 | US20040110171 Identifying transcriptional regulators which control axonal guidance for use as treatments of age related neurodegenerative diseases |
| 06/10/2004 | US20040110170 Cloning and characterization of calcitonin gene related peptide receptors |
| 06/10/2004 | US20040110165 Viral chemokine-antigen fusion proteins |
| 06/10/2004 | US20040110161 Identifying genetic aberrations in nucleic acid sequences using base mispairing-binding proteins; genomics |
| 06/10/2004 | US20040110131 Thrombospondin-1 type 1 repeat polypeptides |
| 06/10/2004 | US20040110127 Screening methods for identifying compounds which decrease HIV entry into a cell |
| 06/10/2004 | US20040110121 Plant-signalling ligand like proteins |
| 06/10/2004 | US20040109887 Immunogenic proteoliposomes, and uses thereof |
| 06/10/2004 | US20040109877 Rna viruses; attenuation influenza virus |
| 06/10/2004 | US20040109876 Vaccine composition, HIV-infection suppression factor and method for the vaccination against HIV |
| 06/10/2004 | US20040109873 Genetic engineering equine herpes virus; genes coding protein |
| 06/10/2004 | US20040109871 Gene, immunogen transfer ; induction mucous membrane immunity; polynucleotide sequences ; bactericides, viricides, fungicides, parasirtici des, anticancer agents |
| 06/10/2004 | US20040109870 Therapeutic agent for acute hepatitis and chronic hepatitis including hepatic fibrosis and cirrhosis |
| 06/10/2004 | US20040109861 Isolated protein complexes; screening analyzing; human t-cell leukemia virus |
| 06/10/2004 | US20040109860 Using immunoglobulins that blocks nerve growth factor; therapy for central nervous system disorders |
| 06/10/2004 | US20040109856 Diagnosis, therapy cancer, tumors |
| 06/10/2004 | US20040109854 Novel traf6 inhibiting protein |
| 06/10/2004 | CA2721200A1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 06/10/2004 | CA2704070A1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 06/10/2004 | CA2507616A1 Highly stable pacap/vip-derived peptides |
| 06/10/2004 | CA2507460A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2507165A1 Optical information carrier comprising immobilized proteorhodopsin |
| 06/10/2004 | CA2506893A1 Methods of protecting against radiation damage using alpha thymosin |
| 06/10/2004 | CA2506820A1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 06/10/2004 | CA2506666A1 Nact as a target for lifespan expansion and weight reduction |
| 06/10/2004 | CA2506633A1 Composition and method for treating lupus nephritis |
| 06/10/2004 | CA2506525A1 Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element |
| 06/10/2004 | CA2506037A1 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 06/10/2004 | CA2505784A1 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | CA2505764A1 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 06/10/2004 | CA2505757A1 Genetic products differentially expressed in tumors and the use thereof |
| 06/10/2004 | CA2504561A1 Composition and method for treating lupus nephritis |
| 06/10/2004 | CA2504287A1 Natriuretic compounds, conjugates, and uses thereof |
| 06/10/2004 | CA2504144A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 06/10/2004 | CA2503736A1 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 06/10/2004 | CA2485950A1 Methods for cohort selection and longevity studies |
| 06/10/2004 | CA2476691A1 Novel proteins and nucleic acids encoding same |
| 06/09/2004 | EP1426765A2 Method for examining the risk of dental caries |
| 06/09/2004 | EP1426444A2 Use of the angiogenic factor VEGF145 in treating cardiovascular diseases |
| 06/09/2004 | EP1426443A1 Novel human bmcc1 gene |
| 06/09/2004 | EP1426442A1 Marker molecules associated with colorectal lesions |
| 06/09/2004 | EP1426440A1 Novel rfrp-3 and dna thereof |
| 06/09/2004 | EP1426382A1 Antiviral human serum albumin |
| 06/09/2004 | EP1426381A1 An epithelial protein and DNA thereof for use in early cancer detection |
| 06/09/2004 | EP1426062A2 Radiolabeled annexins |
| 06/09/2004 | EP1426056A1 Preventives & remedies for bone & joint diseases |
| 06/09/2004 | EP1426055A1 Targeted protein degradation vehicles (tpdvs), nucleic acid constructs encoding them and their use |
| 06/09/2004 | EP1425964A1 Rat highly sensitive to carcinogen |
| 06/09/2004 | EP1425575A1 A novel cancer marker and uses therefor in the diagnosis of cancer |
| 06/09/2004 | EP1425423A2 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
| 06/09/2004 | EP1425421A2 Polymorphisms of pd-1 |
| 06/09/2004 | EP1425420A1 Molecular identification of staphylococcus-type bacteria |
| 06/09/2004 | EP1425418A2 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight |
| 06/09/2004 | EP1425409A2 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 06/09/2004 | EP1425402A2 Improvement of gene expression in vectors |
| 06/09/2004 | EP1425399A2 Combinatorial methods for inducing cancer cell death |
| 06/09/2004 | EP1425397A2 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 06/09/2004 | EP1425396A2 Dna encoding the major allergen of plantago lanceolata pollen, pla 11 |
| 06/09/2004 | EP1425393A1 Screen for cdc7 inhibitors |
| 06/09/2004 | EP1425389A2 Human antibodies specific for interleukin 15 (il-15) |
| 06/09/2004 | EP1425382A2 Novel human collagen proteins and polynucleotides encoding the same |
| 06/09/2004 | EP1425380A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 06/09/2004 | EP1425305A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 06/09/2004 | EP1425304A2 G-csf conjugates |
| 06/09/2004 | EP1425303A2 Use of proteins for the production of a medicament for stimulating the innate non specific immune system |
| 06/09/2004 | EP1425302A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 06/09/2004 | EP1425300A2 PHENOTYPE-DETERMINING VIRULENCE GENES OF i PSEUDOMONAS AERUGINOSA /i FOR COLONIZATION AND PERSISTENCE IN HUMAN BEINGS, ANIMALS AND PLANTS, USES OF SAID GENE AND ASSOCIATED PROTEINS |
| 06/09/2004 | EP1425299A2 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination |
| 06/09/2004 | EP1425298A2 Subunit respiratory syncytial virus vaccine preparation |
| 06/09/2004 | EP1425295A1 Modified peptides and their use for the treatment of autoimmune diseases |
| 06/09/2004 | EP1425289A2 Novel nucleic acid and polypeptide molecules |
| 06/09/2004 | EP1425045A1 Adenoviral vector and related system and methods of making and use |